Skip to main content
main-content

20.08.2018 | Ausgabe 6/2018

Journal of Cancer Survivorship 6/2018

Initial validation of the Danish version of the Fear of Cancer Recurrence Inventory (FCRI) in colorectal cancer patients

Zeitschrift:
Journal of Cancer Survivorship > Ausgabe 6/2018
Autoren:
Ida Hovdenak Jakobsen, Mette Moustgaard Jeppesen, Sébastien Simard, Henriette Vind Thaysen, Søren Laurberg, Therese Juul
Wichtige Hinweise
Requests for permission to use the FCRI (any language versions) should be addressed to Sébastien Simard: Sebastien1_Simard@uqac.ca

Abstract

Purpose

The Fear of Cancer Recurrence Inventory (FCRI) is a multidimensional measure for fear of cancer recurrence (FCR). The aim of this study was to assess the psychometric properties of the translated Danish version of the FCRI in a population of colorectal cancer patients.

Methods

The English version of the FCRI was forward–backward translated into Danish and pilot tested in a gynaecological cancer population. The psychometric properties of the FCRI were assessed in terms of responsiveness, test–retest reliability and discriminative and convergent validity in a population of colorectal cancer patients by asking them to complete questionnaires at three time points during follow-up. Clinical FCR was defined as ≥ 16 at the FCRI short form.

Results

The participation rate was 57%. A low association was found between higher scores on the FCRI and younger age (r = − 0.29, p = 0.02). A moderate correlation was found between the FCRI score and a measure for worry traits (r = 0.49, p < 0.001). Mean difference in total FCRI score was statistically significant between ‘pre-scan’ and ‘postscan’ (p < 0.001), thus indicating that the FCRI was responsive to change. The FCRI score showed good test–retest reliability (intraclass correlation = 0.84).

Conclusion

The Danish version of the FCRI is a reliable and responsive measure for FCR in colorectal cancer patients and shows acceptable discriminative and convergent validity.

Implications for Cancer Survivors

A valid measure for FCR is crucial in order to identify patients with a need for special attention or interventions for high levels of FCR and to improve future research into FCR among cancer survivors.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Weitere Produktempfehlungen anzeigen
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 6/2018

Journal of Cancer Survivorship 6/2018 Zur Ausgabe
  1. Sie können e.Med Innere Medizin 14 Tage kostenlos testen (keine Print-Zeitschrift enthalten). Der Test läuft automatisch und formlos aus. Es kann nur einmal getestet werden.

  2. Das kostenlose Testabonnement läuft nach 14 Tagen automatisch und formlos aus. Dieses Abonnement kann nur einmal getestet werden.